 Voriconazole
"Voriconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
| Descriptor ID |
D065819
|
| MeSH Number(s) |
D03.383.129.799.950
|
| Concept/Terms |
UK 109,496- UK 109,496
- UK-109,496
- UK109,496
- UK-109496
- UK109496
- UK 109496
|
Below are MeSH descriptors whose meaning is more general than "Voriconazole".
Below are MeSH descriptors whose meaning is more specific than "Voriconazole".
This graph shows the total number of publications written about "Voriconazole" by people in this website by year, and whether "Voriconazole" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 4 | 0 | 4 | | 2016 | 1 | 1 | 2 | | 2017 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Voriconazole" by people in Profiles.
-
Henao-Mart?nez AF, Chastain DB, Thompson GR. Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0072123.
-
Krane NA, Beswick DM, Sauer D, Detwiller K, Shindo M. Allergic Fungal Sinusitis Imitating an Aggressive Skull Base Lesion in the Setting of Pembrolizumab Immunotherapy. Ann Otol Rhinol Laryngol. 2021 Jan; 130(1):108-111.
-
Knight-Perry J, Jennissen C, Long SE, Hage S, DeFor TE, Chan WT, Fisher J, Kirstein MN, Smith AR. A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation. Bone Marrow Transplant. 2020 05; 55(5):955-964.
-
Van Matre ET, Evans SL, Mueller SW, MacLaren R, Fish DN, Kiser TH. Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center. Ann Clin Microbiol Antimicrob. 2019 Mar 20; 18(1):13.
-
Benamu E, Yu AT, Xie L, Fernandez-Pol S, Liu AY, Ho DY. Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature. Transpl Infect Dis. 2018 Feb; 20(1).
-
Yi WM, Schoeppler KE, Jaeger J, Mueller SW, MacLaren R, Fish DN, Kiser TH. Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study. Ann Clin Microbiol Antimicrob. 2017 Sep 11; 16(1):60.
-
Harrington R, Lee E, Yang H, Wei J, Messali A, Azie N, Wu EQ, Spalding J. Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis. Adv Ther. 2017 01; 34(1):207-220.
-
Andes D, Azie N, Yang H, Harrington R, Kelley C, Tan RD, Wu EQ, Franks B, Kristy R, Lee E, Khandelwal N, Spalding J. Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients. Antimicrob Agents Chemother. 2016 06; 60(6):3398-406.
-
Balla A, Pierson J, Hugh J, Wojewoda C, Gibson P, Greene L. Disseminated cutaneous Curvularia infection in an immunocompromised host; diagnostic challenges and experience with voriconazole. J Cutan Pathol. 2016 Apr; 43(4):383-7.
-
Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):262-70.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|